|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
AU2003267991B2
(en)
*
|
2002-07-11 |
2009-10-08 |
Vicuron Pharmaceuticals, Inc. |
N-hydroxyamide derivatives possessing antibacterial activity
|
|
SG159388A1
(en)
*
|
2003-01-08 |
2010-03-30 |
Chiron Corp |
Antibacterial agents
|
|
WO2005012256A1
(en)
|
2003-07-22 |
2005-02-10 |
Astex Therapeutics Limited |
3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
|
|
US7432281B2
(en)
|
2003-10-07 |
2008-10-07 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
AR047334A1
(es)
*
|
2003-12-19 |
2006-01-18 |
Basf Ag |
Fenilalanina-amidas sustituidas por benzoilo
|
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
|
US7638513B2
(en)
|
2004-06-02 |
2009-12-29 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
WO2006022442A1
(ja)
*
|
2004-08-24 |
2006-03-02 |
Santen Pharmaceutical Co., Ltd. |
ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
|
|
US7776869B2
(en)
|
2004-10-18 |
2010-08-17 |
Amgen Inc. |
Heteroaryl-substituted alkyne compounds and method of use
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
US20090088433A1
(en)
|
2005-01-26 |
2009-04-02 |
Bertrand Leblond |
Methods of using as analgesics 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds
|
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
US20080300243A1
(en)
*
|
2005-02-28 |
2008-12-04 |
Kelly Michael G |
Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
|
|
US8999289B2
(en)
|
2005-03-22 |
2015-04-07 |
President And Fellows Of Harvard College |
Treatment of protein degradation disorders
|
|
UA94412C2
(en)
*
|
2005-07-11 |
2011-05-10 |
Уайет |
Glutamate aggrecanase inhibitors
|
|
JP4961773B2
(ja)
*
|
2005-07-29 |
2012-06-27 |
住友ベークライト株式会社 |
芳香族カルボン酸及びその酸ハロゲン化物
|
|
EP2338878A3
(en)
*
|
2005-12-15 |
2011-11-16 |
Vicuron Pharmaceuticals, Inc. |
N-hydroxyamide derivatives possessing antibacterial activity
|
|
US8222423B2
(en)
*
|
2006-02-14 |
2012-07-17 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional histone deacetylase inhibitors
|
|
AU2007248656B2
(en)
|
2006-05-03 |
2013-04-04 |
Dana-Farber Cancer Institute, Inc. |
Histone deacetylase and tubulin deacetylase inhibitors
|
|
KR20090010092A
(ko)
|
2006-05-30 |
2009-01-28 |
아스트라제네카 아베 |
Ｄｇａｔ1 억제제로서의 1,3,4-옥사디아졸 유도체
|
|
DE102006033321A1
(de)
*
|
2006-07-17 |
2008-01-24 |
Westfälische Wilhelms-Universität Münster |
Medizinische Verwendung von N-Phenylpropenoyl-Aminosäurederivaten und verwandten Verbindungen
|
|
JP2009544611A
(ja)
|
2006-07-20 |
2009-12-17 |
メルク エンド カムパニー インコーポレーテッド |
ヒストン脱アセチル化酵素阻害剤としてのリン誘導体
|
|
WO2008014266A2
(en)
*
|
2006-07-24 |
2008-01-31 |
University Of Maryland, Baltimore |
Heme oxygenase inhibitors and methods of therapeutic use
|
|
TW200821276A
(en)
*
|
2006-08-18 |
2008-05-16 |
Leo Pharma As |
Substituted acetylenic compounds useful for the treatment of diseases
|
|
JP2010502617A
(ja)
|
2006-08-31 |
2010-01-28 |
シェーリング コーポレイション |
抗菌物質として有用なヒダントイン誘導体
|
|
US7923004B2
(en)
*
|
2006-10-13 |
2011-04-12 |
Xtl Biopharmaceuticals Ltd. |
4-ethynyl pyrazole derivative compounds and methods for treatment of HCV
|
|
JP5043120B2
(ja)
|
2006-10-30 |
2012-10-10 |
クロマ セラピューティクス リミテッド |
ヒストンデアセチラーゼの阻害剤としてのヒドロキサメート
|
|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
JP5227304B2
(ja)
*
|
2007-02-28 |
2013-07-03 |
大正製薬株式会社 |
新規なヒドロキサム酸誘導体
|
|
CN101686680B
(zh)
|
2007-03-09 |
2015-12-09 |
伊沃泰克美国股份有限公司 |
作为p2x7调节剂的双环杂芳基化合物及其用途
|
|
CA2934114A1
(en)
*
|
2007-06-12 |
2008-12-18 |
Achaogen, Inc. |
Antibacterial agents
|
|
CN101417937B
(zh)
*
|
2007-10-23 |
2013-05-29 |
中山大学 |
β-醛酮类抗菌化合物及其应用
|
|
CA2708281A1
(en)
|
2007-12-11 |
2009-08-27 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
|
|
JP5662803B2
(ja)
|
2007-12-20 |
2015-02-04 |
アストラゼネカ アクチボラグ |
Ｄｇａｔ１阻害剤としてのカルバモイル化合物１９０
|
|
WO2009158369A1
(en)
|
2008-06-25 |
2009-12-30 |
Schering Corporation |
Synthesis and use of heterocyclic antibacterial agents
|
|
US8440716B2
(en)
|
2008-07-23 |
2013-05-14 |
President And Fellows Of Harvard College |
Deacetylase inhibitors and uses thereof
|
|
CA2733390A1
(en)
*
|
2008-08-01 |
2010-02-04 |
Bioxiness Pharmaceuticals, Inc. |
Methionine analogs and methods of using same
|
|
EP2315746A1
(en)
*
|
2008-08-04 |
2011-05-04 |
Schering Corporation |
Urea derivatives as antibacterial agents
|
|
US8273900B2
(en)
|
2008-08-07 |
2012-09-25 |
Novartis Ag |
Organic compounds
|
|
US8372885B2
(en)
*
|
2008-09-17 |
2013-02-12 |
Novartis Ag |
Organic compounds and their uses
|
|
US8722686B2
(en)
|
2008-09-19 |
2014-05-13 |
Pfizer Inc. |
Hydroxamic acid derivatives useful as antibacterial agents
|
|
WO2010043721A1
(en)
|
2008-10-17 |
2010-04-22 |
Oryzon Genomics, S.A. |
Oxidase inhibitors and their use
|
|
EP2177502A1
(en)
*
|
2008-10-17 |
2010-04-21 |
Oryzon Genomics, S.A. |
Compounds and their use
|
|
US8993808B2
(en)
|
2009-01-21 |
2015-03-31 |
Oryzon Genomics, S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
|
WO2011005355A1
(en)
|
2009-05-07 |
2011-01-13 |
Achaogen, Inc. |
Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
|
|
KR20120023663A
(ko)
*
|
2009-05-25 |
2012-03-13 |
키에시 파르마슈티시 엣스. 피. 에이. |
폐 계면활성제 및 스테로이드를 포함하는 치료적 조합
|
|
MX2011014018A
(es)
|
2009-06-19 |
2012-02-22 |
Astrazeneca Ab |
Pirazincarboxamidas como inhibidores de dgati.
|
|
US8716344B2
(en)
|
2009-08-11 |
2014-05-06 |
President And Fellows Of Harvard College |
Class- and isoform-specific HDAC inhibitors and uses thereof
|
|
FR2950056B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
FR2950057B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
US8859555B2
(en)
|
2009-09-25 |
2014-10-14 |
Oryzon Genomics S.A. |
Lysine Specific Demethylase-1 inhibitors and their use
|
|
EP2486002B1
(en)
|
2009-10-09 |
2019-03-27 |
Oryzon Genomics, S.A. |
Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use
|
|
PL2512474T3
(pl)
*
|
2009-12-16 |
2015-03-31 |
Pfizer |
N-przyłączone pochodne kwasu hydroksamowego użyteczne jako środki przeciwbakteryjne
|
|
WO2011106573A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
|
US9616058B2
(en)
|
2010-02-24 |
2017-04-11 |
Oryzon Genomics, S.A. |
Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for antiviral use
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
MX2012012111A
(es)
|
2010-04-19 |
2013-05-30 |
Oryzon Genomics Sa |
Inhibidores de demetilasa-1 especifica de lisina y su uso.
|
|
SG184958A1
(en)
*
|
2010-04-20 |
2012-11-29 |
Taisho Pharmaceutical Co Ltd |
Novel hydroxamic acid derivative
|
|
CN105130948A
(zh)
|
2010-04-22 |
2015-12-09 |
弗特克斯药品有限公司 |
制备环烷基甲酰胺基-吲哚化合物的方法
|
|
WO2012013727A1
(en)
|
2010-07-29 |
2012-02-02 |
Oryzon Genomics S.A. |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
|
SI2598482T1
(sl)
|
2010-07-29 |
2018-09-28 |
Oryzon Genomics, S.A. |
Inhibitorji demetilaze lsd1 na osnovi arilciklopropilamina in njihova medicinska uporaba
|
|
WO2012031298A2
(en)
|
2010-09-03 |
2012-03-08 |
Duke University |
Ethynylbenzene derivatives
|
|
WO2012045883A1
(en)
|
2010-10-08 |
2012-04-12 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
|
AR083760A1
(es)
*
|
2010-11-10 |
2013-03-20 |
Achaogen Inc |
Agentes antibacterianos y composiciones farmaceuticas
|
|
WO2012072713A2
(en)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
|
|
KR20140027090A
(ko)
|
2011-01-04 |
2014-03-06 |
노파르티스 아게 |
연령-관련 황반 변성 (amd)의 치료에 유용한 인돌 화합물 또는 그의 유사체
|
|
WO2012107498A1
(en)
|
2011-02-08 |
2012-08-16 |
Oryzon Genomics S.A. |
Lysine demethylase inhibitors for myeloproliferative disorders
|
|
US8877940B2
(en)
|
2011-02-22 |
2014-11-04 |
Institut National De La Recherche Scientifique |
Antibiotic tolerance inhibitors
|
|
GEP20156370B
(en)
|
2011-03-07 |
2015-09-25 |
Pfizer |
Fluoro-pyridinone derivatives useful as antibacterial agents
|
|
EP2694481B1
(en)
|
2011-04-08 |
2015-12-30 |
Pfizer Inc |
Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
|
|
EP2694488B1
(en)
|
2011-04-08 |
2014-11-12 |
Pfizer Inc |
Isoxazole derivatives useful as antibacterial agents
|
|
US20150203444A1
(en)
|
2011-09-12 |
2015-07-23 |
Achaogen, Inc. |
Polymorphs of n-((s)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1r,2r)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzamide
|
|
JP6006609B2
(ja)
*
|
2011-10-19 |
2016-10-12 |
大正製薬株式会社 |
新規なヒドロキサム酸誘導体を含有する医薬
|
|
RS58475B1
(sr)
|
2011-10-20 |
2019-04-30 |
Oryzon Genomics Sa |
Jedinjenja (hetero)aril ciklopropilamina kao lsd1 inhibitori
|
|
CN107266345B
(zh)
|
2011-10-20 |
2021-08-17 |
奥瑞泽恩基因组学股份有限公司 |
作为lsd1抑制剂的(杂)芳基环丙胺化合物
|
|
EP2814807A4
(en)
*
|
2012-02-16 |
2015-10-07 |
Rqx Pharmaceuticals Inc |
LINEAR PEPTIDANTIBIOTICS
|
|
EP2847168A1
(en)
|
2012-05-10 |
2015-03-18 |
Achaogen, Inc. |
Antibacterial agents
|
|
EP2867229B1
(en)
|
2012-06-28 |
2017-07-26 |
Novartis AG |
Pyrrolidine derivatives and their use as complement pathway modulators
|
|
JP6273274B2
(ja)
|
2012-06-28 |
2018-01-31 |
ノバルティス アーゲー |
補体経路モジュレーターおよびその使用
|
|
ES2712190T3
(es)
|
2012-06-28 |
2019-05-09 |
Novartis Ag |
Moduladores de la vía del complemento y sus usos
|
|
EP2867225B1
(en)
|
2012-06-28 |
2017-08-09 |
Novartis AG |
Pyrrolidine derivatives and their use as complement pathway modulators
|
|
WO2014002053A1
(en)
|
2012-06-28 |
2014-01-03 |
Novartis Ag |
Pyrrolidine derivatives and their use as complement pathway modulators
|
|
EP2872503B1
(en)
|
2012-07-12 |
2018-06-20 |
Novartis AG |
Complement pathway modulators and uses thereof
|
|
CN103012207B
(zh)
*
|
2012-12-29 |
2015-05-27 |
吉首大学 |
二芳基丙酰-n-甲基氧肟酸类尿素酶抑制剂及其合成和用途
|
|
WO2014165075A1
(en)
*
|
2013-03-12 |
2014-10-09 |
Achaogen, Inc. |
Antibacterial agents
|
|
LT2975022T
(lt)
|
2013-03-15 |
2019-07-25 |
Fujifilm Toyama Chemical Co., Ltd. |
Naujas hidroksamo rūgšties darinys arba jo druska
|
|
WO2014160649A1
(en)
*
|
2013-03-29 |
2014-10-02 |
Novartis Ag |
Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections
|
|
US10647664B2
(en)
|
2013-08-16 |
2020-05-12 |
Duke University |
Substituted hydroxamic acid compounds
|
|
WO2015024016A2
(en)
|
2013-08-16 |
2015-02-19 |
Duke University |
2-piperidinyl substituted n,3-dihydroxybutanamides
|
|
US10189786B2
(en)
*
|
2013-08-16 |
2019-01-29 |
Duke University |
Antibacterial compounds
|
|
GB201315335D0
(en)
|
2013-08-29 |
2013-10-09 |
Of Singapore |
Amino diacids containing peptide modifiers
|
|
US9539305B1
(en)
|
2014-03-14 |
2017-01-10 |
Fleurir Abx Llc |
Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
|
|
JP6543268B2
(ja)
|
2014-04-15 |
2019-07-10 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
嚢胞性線維症膜コンダクタンス調節因子が媒介する疾患を処置するための医薬組成物
|
|
EP3134401B1
(en)
|
2014-04-22 |
2018-06-13 |
Novartis AG |
Isoxazoline hydroxamic acid derivatives as lpxc inhibitors
|
|
WO2016039432A1
(ja)
|
2014-09-12 |
2016-03-17 |
富山化学工業株式会社 |
新規なヒドロキサム酸誘導体および抗菌性物質を組み合わせて使用する方法
|
|
JPWO2016039433A1
(ja)
|
2014-09-12 |
2017-06-22 |
富山化学工業株式会社 |
新規なヒドロキサム酸誘導体またはその塩を含有する医薬組成物
|
|
CN104327140B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁唑烷酮-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104231024B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-肌苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104341475A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104262433B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-腺苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104341476A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-肌苷型多靶点抗菌化合物及其制法和用途
|
|
CU24443B1
(es)
|
2014-12-16 |
2019-10-04 |
Novartis Ag |
COMPUESTOS DE ISOXAZOL DE ÁCIDO HIDROXÁMICO COMO INHIBIDORES DE LpxC
|
|
CN105777464B
(zh)
*
|
2014-12-26 |
2020-09-29 |
中国科学院上海药物研究所 |
异羟肟酸衍生物及其制备方法和应用
|
|
WO2016198691A1
(en)
|
2015-06-11 |
2016-12-15 |
Basilea Pharmaceutica Ag |
Efflux-pump inhibitors and therapeutic uses thereof
|
|
WO2017042099A1
(en)
*
|
2015-09-09 |
2017-03-16 |
Basilea Pharmaceutica Ag |
Efflux-pump inhibitors and therapeutic uses thereof
|
|
WO2017083434A1
(en)
|
2015-11-09 |
2017-05-18 |
Forge Therapeutics, Inc. |
Pyrone based compounds for treating bacterial infections
|
|
WO2017083431A2
(en)
|
2015-11-09 |
2017-05-18 |
Forge Therapeutics, Inc. |
Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
|
|
RU2018124788A
(ru)
*
|
2015-12-08 |
2020-01-15 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Замещенные бензазиноны в качестве антибактериальных соединений
|
|
EP3426674A4
(en)
|
2016-03-09 |
2019-08-14 |
Blade Therapeutics, Inc. |
CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
CA3021152A1
(en)
*
|
2016-04-18 |
2017-10-26 |
Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. |
Inhibitors of meprin alpha and beta
|
|
EP3448375B1
(en)
*
|
2016-04-25 |
2023-09-27 |
Duke University |
Benzoylglycine derivatives and methods of making and using same
|
|
HRP20201524T1
(hr)
|
2016-06-14 |
2021-03-05 |
Novartis Ag |
Kristalni oblik (r)-4-(5-(ciklopropiletinil) izoksazol-3 -il)-n-hidroksi-2-metil-2-(metilsufonil) butanamid kao antibakterijsko sredstvo
|
|
WO2017222914A1
(en)
|
2016-06-21 |
2017-12-28 |
Inception 4, Inc. |
Carbocyclic prolinamide derivatives
|
|
JP7076438B2
(ja)
|
2016-06-21 |
2022-05-27 |
オリオン・オフサルモロジー・エルエルシー |
脂肪族プロリンアミド誘導体
|
|
EP4257191A3
(en)
|
2016-06-21 |
2023-11-22 |
Orion Ophthalmology LLC |
Heterocyclic prolinamide derivatives
|
|
WO2017223349A1
(en)
|
2016-06-23 |
2017-12-28 |
Achaogen, Inc. |
Antibacterial agents
|
|
EP3481835A4
(en)
|
2016-07-05 |
2020-02-26 |
Blade Therapeutics, Inc. |
CALPAIN MODULATORS AND THERAPEUTIC USE THEREOF
|
|
SG10201912574WA
(en)
|
2016-09-28 |
2020-02-27 |
Blade Therapeutics Inc |
Calpain modulators and therapeutic uses thereof
|
|
WO2018115421A1
(en)
*
|
2016-12-23 |
2018-06-28 |
Intervet International B.V. |
Compounds useful for treating a mannheimia haemolytica or histophilus somni infection
|
|
JP7082445B2
(ja)
|
2016-12-23 |
2022-06-08 |
インターベット インターナショナル ベー． フェー． |
ウシ又はブタの呼吸器疾患を治療するための化合物
|
|
EP3621962A4
(en)
|
2017-05-10 |
2020-12-09 |
Forge Therapeutics, Inc. |
ANTIBACTERIAL COMPOUNDS
|
|
WO2018213185A1
(en)
*
|
2017-05-17 |
2018-11-22 |
Drexel University |
Rela inhibitors for biofilm disruption
|
|
CA3069720A1
(en)
|
2017-07-11 |
2019-01-17 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
AU2018306420B2
(en)
*
|
2017-07-27 |
2024-02-15 |
BioMendics, LLC |
Substituted tolans for the modulation of microbial colonization
|
|
BR112020016270A2
(pt)
*
|
2018-02-10 |
2020-12-15 |
Kbp Biosciences Co., Ltd. |
Composto atuando como antibióticos
|
|
CA3113226A1
(en)
*
|
2018-09-20 |
2020-03-26 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
KR102630416B1
(ko)
|
2018-10-30 |
2024-02-01 |
길리애드 사이언시즈, 인코포레이티드 |
알파4베타7 인테그린 억제제로서의 퀴놀린 유도체
|
|
US11179383B2
(en)
|
2018-10-30 |
2021-11-23 |
Gilead Sciences, Inc. |
Compounds for inhibition of α4β7 integrin
|
|
ES3013256T3
(en)
|
2018-10-30 |
2025-04-11 |
Gilead Sciences Inc |
Imidazo[1,2-a]pyridine derivatives as alpha4beta7 integrin inhibitors for the treatment of inflammatory diseases
|
|
AU2019373242B2
(en)
|
2018-10-30 |
2023-07-13 |
Gilead Sciences, Inc. |
Compounds for inhibition of alpha 4 beta 7 integrin
|
|
WO2020146682A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
JP2022521600A
(ja)
*
|
2019-02-22 |
2022-04-11 |
シラ セラピューティック インコーポレイティッド |
吸入可能な治療剤
|
|
CN114222730B
(zh)
|
2019-08-14 |
2024-09-10 |
吉利德科学公司 |
用于抑制α4β7整合素的化合物
|
|
CN110563611B
(zh)
|
2019-09-19 |
2021-02-02 |
中国医学科学院医药生物技术研究所 |
一种异羟肟酸类衍生物及其制备方法和应用
|
|
MX2022006865A
(es)
|
2019-12-06 |
2022-07-11 |
Vertex Pharma |
Tetrahidrofuranos sustituidos como moduladores de canales de sodio.
|
|
CN111254091B
(zh)
*
|
2020-01-20 |
2022-04-19 |
浙江工业大学 |
一种嗜麦芽窄食单胞菌gyh及其在降解氯代烃类污染物中的应用
|
|
WO2021195260A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor and methods of making
|
|
IL298324A
(en)
|
2020-06-10 |
2023-01-01 |
Aligos Therapeutics Inc |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|
|
CN117794920A
(zh)
|
2021-06-04 |
2024-03-29 |
沃泰克斯药物股份有限公司 |
N-(羟烷基(杂)芳基)四氢呋喃甲酰胺作为钠通道调节剂
|
|
CA3224494A1
(en)
|
2021-07-09 |
2023-01-12 |
Koen Vandyck |
Anti-viral compounds
|
|
WO2023043816A1
(en)
|
2021-09-17 |
2023-03-23 |
Aligos Therapeutics, Inc. |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|
|
CA3233328A1
(en)
|
2021-09-28 |
2023-04-06 |
Min Teng |
Lpxc inhibitors and uses thereof
|
|
WO2023128033A1
(ko)
*
|
2021-12-31 |
2023-07-06 |
(주)앰틱스바이오 |
감염성 진균의 바이오필름 생성을 억제하는 신규한 항진균용 조성물
|
|
CN116730870B
(zh)
*
|
2023-08-08 |
2023-10-13 |
中国医学科学院医药生物技术研究所 |
异羟肟酸类化合物或其可药用盐、及其用途和制备方法
|
|
CN119350185A
(zh)
*
|
2024-10-08 |
2025-01-24 |
聊城大学 |
一种联苯羟肟类衍生物及其制备方法和用途
|